- Home
- HAYN vs SANA Comparison
HAYN vs SANA Comparison
Compare HAYN & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAYN
- SANA
- Stock Information
- Founded
- HAYN 1912
- SANA 2018
- Country
- HAYN United States
- SANA United States
- Employees
- HAYN N/A
- SANA N/A
- Industry
- HAYN Steel/Iron Ore
- SANA Medicinal Chemicals and Botanical Products
- Sector
- HAYN Industrials
- SANA Health Care
- Exchange
- HAYN Nasdaq
- SANA Nasdaq
- Market Cap
- HAYN 772.3M
- SANA 887.6M
- IPO Year
- HAYN N/A
- SANA 2021
- Fundamental
- Price
- HAYN $60.99
- SANA $2.35
- Analyst Decision
- HAYN Hold
- SANA Strong Buy
- Analyst Count
- HAYN 2
- SANA 3
- Target Price
- HAYN N/A
- SANA $11.50
- AVG Volume (30 Days)
- HAYN 243.4K
- SANA 1.7M
- Earning Date
- HAYN 11-26-2024
- SANA 11-08-2024
- Dividend Yield
- HAYN 1.44%
- SANA N/A
- EPS Growth
- HAYN N/A
- SANA N/A
- EPS
- HAYN 2.90
- SANA N/A
- Revenue
- HAYN $614,334,000.00
- SANA N/A
- Revenue This Year
- HAYN $4.57
- SANA N/A
- Revenue Next Year
- HAYN $2.32
- SANA N/A
- P/E Ratio
- HAYN $21.04
- SANA N/A
- Revenue Growth
- HAYN 7.18
- SANA N/A
- 52 Week Low
- HAYN $47.77
- SANA $2.29
- 52 Week High
- HAYN $61.01
- SANA $12.00
- Technical
- Relative Strength Index (RSI)
- HAYN 68.93
- SANA 25.85
- Support Level
- HAYN $60.25
- SANA $2.29
- Resistance Level
- HAYN $60.86
- SANA $3.02
- Average True Range (ATR)
- HAYN 0.20
- SANA 0.29
- MACD
- HAYN 0.02
- SANA -0.05
- Stochastic Oscillator
- HAYN 97.50
- SANA 3.95
About HAYN Haynes International Inc.
Haynes International Inc is a producer of high-performance nickel and cobalt-based alloys. The company is focused on developing, manufacturing, marketing, and distributing technology and high-performance alloys. The company operates in a single segment: the design, manufacture, marketing, and distribution of technologically advanced, high-performance alloys for use in the aerospace, industrial gas turbine, chemical processing, and other industries Geographically, it derives a majority of revenue from the United States and also has a presence in Europe, China, and other countries.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.